Causes of induction failure in newly diagnosed acute promyelocytic leukemia patients treated with simultaneous ATRA and idarubicin (AIDA).

被引：0
|
作者：
de la Serna, J
Martin, G
Vellenga, E
Rayon, C
Rivas, C
Deben, G
Gonzalez, M
Tormo, M
Bergua, J
Diaz-Mediavilla, J
Leon, A
Esteve, J
Parody, R
Amutio, E
Gonzalez, JD
Negri, S
Capote, FJ
Bueno, J
Perez-Encina, M
Novo, A
Rodriguez, A
Sanz, MA
机构：
来源：
BLOOD | 2004年 / 104卷 / 11期
关键词：
D O I：
10.1182/blood.V104.11.887.887
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
887
引用
收藏
页码：253A / 253A
页数：1
相关论文
共 50 条
  • [41] INDUCTION THERAPY WITH '3+7'CHEMOTHERAPY PLUS ATRA FOLLOWED BY CONSOLIDATIONS WITH THREE COURSES OF IDARUBICIN ALONE AND MAINTENANCE THERAPY WITH ATRA IN NEWLY DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA HAS AN EXCELLENT LEUKEMIA-FREE SURVIVAL BUT MINIMAL TOXICITY IN LOW AND INTERMEDIATE RISK GROU
    Mun, Y. C.
    Choi, M. Y.
    Cho, E. K.
    Lee, J. H.
    Jo, D. Y.
    Kim, I. H.
    Bang, S. M.
    Yoon, S. S.
    Park, S. Y.
    Kim, B. K.
    Kim, H.
    Min, Y. J.
    Park, J. H.
    Seo, J. J.
    Moon, H. N.
    Lee, M. H.
    Kim, C. S.
    Lee, W. S.
    Joo, Y. D.
    Chung, S. Y.
    Oh, D. Y.
    Zang, D. Y.
    Lee, K. H.
    Hyun, M. S.
    Song, H. S.
    Kim, H. S.
    Kim, S. H.
    Kwon, H. C.
    Kim, H. J.
    Ahn, M. J.
    Ahn, J. S.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 123 - 123
  • [42] Prognostic factors of patients with newly diagnosed acute promyelocytic leukemia treated with arsenic trioxide-based frontline therapy
    Lou, Yinjun
    Ma, Yafang
    Suo, Shanshan
    Ni, Wanmao
    Wang, Yungui
    Pan, Hanzhang
    Tong, Hongyan
    Qian, Wenbin
    Meng, Haitao
    Mai, Wenyuan
    Huang, Jian
    Yu, Wenjuan
    Wei, Juyin
    Mao, Liping
    Jin, Jie
    LEUKEMIA RESEARCH, 2015, 39 (09) : 938 - 944
  • [43] Treatment of newly diagnosed patients with acute promyelocytic leukemia with modified spanish treatment protocol
    Oravcova, I.
    Czako, B.
    Demeckova, E.
    Demitrovicova, L.
    Greksak, R.
    Kotoucek, P.
    Mego, M.
    Mikuskova, E.
    Richterova, K.
    Al Sabti, F.
    Mistrik, M.
    NEOPLASMA, 2010, 57 (03) : 270 - 279
  • [44] Influence of cytokines on early death and coagulopathy in newly diagnosed patients with acute promyelocytic leukemia
    Zhao, Shixiang
    Ge, Yuanyuan
    Li, Zengzheng
    Yang, Tonghua
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [45] A randomized comparison of all transretinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia
    Fenaux, P
    Chastang, C
    Chevret, S
    Sanz, M
    Dombret, H
    Archimbaud, E
    Fey, M
    Rayon, C
    Huguet, F
    Sotto, JJ
    Gardin, C
    Makhoul, PC
    Travade, P
    Solary, E
    Fegueux, N
    Bordessoule, D
    San Miguel, J
    Link, H
    Desablens, B
    Stamatoullas, A
    Deconinck, E
    Maloisel, F
    Castaigne, S
    Preudhomme, C
    Degos, L
    BLOOD, 1999, 94 (04) : 1192 - 1200
  • [46] RESULTS OF AIDA-BASED TREATMENT FOR CHILDREN WITH NEWLY DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA - A SINGLE BRAZILIAN-CENTER EXPERIENCE
    Teixeira, R. A. P.
    Jardini, V. M. G.
    Sanglard, W. O.
    Costa, C. R.
    Teles, T. A.
    Silva, M. M.
    PEDIATRIC BLOOD & CANCER, 2014, 61 : S327 - S327
  • [47] Pathologic rupture of the spleen during induction with ATRA in a patient with acute promyelocytic leukemia
    R Hernández
    MC del Cañizo
    C López
    MI González
    ML Vázquez
    MD Caballero
    JF San Miguel
    Medical Oncology, 2000, 17 : 337 - 339
  • [48] PML–RARα kinetics and impact of FLT3–ITD mutations in newly diagnosed acute promyelocytic leukaemia treated with ATRA and ATO or ATRA and chemotherapy
    L Cicconi
    M Divona
    C Ciardi
    T Ottone
    A Ferrantini
    S Lavorgna
    V Alfonso
    F Paoloni
    A Piciocchi
    G Avvisati
    F Ferrara
    E Di Bona
    F Albano
    M Breccia
    E Cerqui
    M Sborgia
    M G Kropp
    A Santoro
    A Levis
    S Sica
    S Amadori
    M T Voso
    F Mandelli
    F Lo-Coco
    Leukemia, 2016, 30 : 1987 - 1992
  • [49] Induction Therapy with "3+7" Chemotherapy Plus ATRA Followed by Consolidations with Three Courses of Idarubicin Alone and Maintenance Therapy with ATRA in Newly Diagnosed Acute Promyelocytic Leukemia (APL) Has An Excellent Leukemia-Free Survival but Minimal Toxicity in Low and Intermediate Risk Groups
    Choi, Moon-Young
    Mun, Yeung-Chul
    Park, Se Hoon
    Cho, Eun Kyung
    Lee, Jae Hoon
    Jo, Deog Yeon
    Kim, Inho
    Bang, Soo-Mee
    Yoon, Sung-Soo
    Park, Seonyang
    Kim, Byoung Kook
    Kim, Hawk
    Min, Young Joo
    Park, Jae Hoo
    Seo, Jong Jin
    Moon, Hyung Nam
    Lee, Moon Hee
    Kim, Cheol Soo
    Lee, Won Sik
    Joo, Young Don
    Chung, So Young
    Oh, Doyeun
    Zang, Dae Young
    Lee, Kyung Hee
    Hyun, Myung Soo
    Song, Hong Suk
    Kim, Heung Sik
    Kim, Sung Hyun
    Kwon, Hyuk Chan
    Kim, Hyo Jin
    Park, Kyung Tae
    Ahn, Jin Seok
    Park, Yeon Hee
    Ahn, Myung Ju
    Bae, Sung Hwa
    Ryoo, Hun-Mo
    Choi, Jung-Hye
    Yoon, Hwi-Joong
    Nam, Seung-Hyun
    Kim, Bong-Seog
    Ghim, Thad T.
    Seong, Chu-Myong
    BLOOD, 2009, 114 (22) : 817 - 818
  • [50] Pathologic rupture of the spleen during induction with ATRA in a patient with acute promyelocytic leukemia
    Hernández, R
    del Cañizo, MC
    López, C
    González, MI
    Vázquez, ML
    Caballero, MD
    San Miguel, JF
    MEDICAL ONCOLOGY, 2000, 17 (04) : 337 - 339
12345